Vanderbilt University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).

430 total trials 15 currently recruiting 343 completed early-phase tilt top decile by trial count

Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.

Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

430 total, page 6 of 9

COMPLETED NA

Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)

NCT00797615

COMPLETED NA

Effect of Exercise in OI

NCT00770484

TERMINATED NA

Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?

NCT00802633

COMPLETED Phase 4

Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome

NCT00775671

TERMINATED NA

Project Diabetes: Prescription for Healthy Living

NCT00775216

COMPLETED NA

Brain Retraction Monitoring Sensor Study

NCT00754754

COMPLETED NA

Aldosterone and Glucose Homeostasis

NCT00732160

COMPLETED

Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)

NCT00911703

COMPLETED Phase 3

High Fat Diet: Oxidative and Cardiovascular Effects

NCT00696228

COMPLETED NA

The Autonomic Nervous System and the Metabolic Syndrome

NCT00580957

COMPLETED Phase 2

Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid

NCT00729924

COMPLETED Phase 2

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

NCT00732069

COMPLETED NA

Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis

NCT00880906

COMPLETED NA

A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial

NCT00715494

COMPLETED

Microenvironment of Adipose Tissue in Endocannabinoid System

NCT00978289

COMPLETED

Autonomic Failure Patients for RNA Blood Sampling

NCT00742586

COMPLETED Phase 2

ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity

NCT00808431

COMPLETED NA

Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care

NCT00715585

COMPLETED

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

NCT00875238

COMPLETED

PAR Regulation of Platelet Function in Diabetic Patients

NCT00855374

COMPLETED NA

Brief Primary Care Intervention Helps Parents With Discipline

NCT00875303

COMPLETED

Head & Neck Cancer Survivorship: Physical and Functional Status

NCT00751816

TERMINATED

Effects of Oxygen on Lung Tissue During Anesthesia

NCT00715338

COMPLETED Phase 2

Peripheral Dopamine in Postural Tachycardia Syndrome

NCT00685919

COMPLETED

Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer

NCT00840814

TERMINATED

Evaluation of the Patient Safety Screening Tool (PSST) for Sepsis

NCT00698542

COMPLETED Phase 2

Vitamin D, Insulin Resistance and Inflammation in ESRD

NCT00656032

COMPLETED Phase 2

Omega-3 Fatty Acid Administration in Dialysis Patients

NCT00655525

COMPLETED NA

Energy Balance Interventions for Colorectal Cancer Prevention

NCT00653484

COMPLETED

NTX Wireless Patient Monitoring System

NCT00654693

COMPLETED Phase 4

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

NCT00666848

COMPLETED Phase 1

6R-BH4 Pulmonary Arterial Hypertension Study

NCT00435331

COMPLETED

Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea

NCT00936481

COMPLETED Phase 1

Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy

NCT00620711

COMPLETED NA

Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients

NCT00420290

COMPLETED Phase 1

Melatonin for Sleep in Children With Autism

NCT00927030

COMPLETED NA

Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

NCT00685945

COMPLETED Phase 4

Effect of Aldosterone on Energy Starvation in Heart Failure

NCT00574119

TERMINATED

Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release

NCT00655915

TERMINATED Phase 2

Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease

NCT00581269

COMPLETED Phase 4

Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation

NCT00552084

COMPLETED Phase 4

Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?

NCT00571688

COMPLETED

Retrospective Postoperative ARDS Study at Vanderbilt University

NCT00656071

TERMINATED Phase 1

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

NCT00517582

COMPLETED Phase 2

Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

NCT00515216

COMPLETED

Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up

NCT00478894

TERMINATED

WiiMote Game Controller as a Device to Study Movement Disorders

NCT00802191

COMPLETED

Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment

NCT00538122

TERMINATED NA

Biomet Humeral Stem Data Collection

NCT00553527

TERMINATED

Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

NCT00670605

← Previous Page 6 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 42
Phase 3 10
Phase 4 32

What is open in the Vanderbilt University pipeline

15 recruiting of 430 indexed (3% open); 343 completed (80%).

Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University: open-pipeline peers nationwide

Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Vanderbilt UniversityUniversity of Illinois at ChicagoChildren's Hospital of PhiladelphiaNovo Nordisk A/SDartmouth-Hitchcock Medical CenterUSDA Grand Forks Human Nutrition Research CenterMedtronic MiniMedSandozSonova
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 430 trials (± recruiting share)

Sponsors near 3% open enrollment (± trial volume)

What to do with this Vanderbilt University page

430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.

  • 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.